Tricuspid regurgitation screening
|
Tricuspid Regurgitation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tricuspid regurgitation screening On the Web |
|
American Roentgen Ray Society Images of Tricuspid regurgitation screening |
|
Risk calculators and risk factors for Tricuspid regurgitation screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Basir Gill, M.B.B.S, M.D.[2]
Overview
Routine population screening for tricuspid regurgitation is not recommended. Targeted evaluation may be appropriate in patients with atrial fibrillation, pulmonary hypertension, heart failure with preserved ejection fraction, or prior left-sided valve surgery. Moreover, there are some genetic conditions which might lead to tricuspid valve regurgitation and can be screened.
Screening[1]
- Patients with atrial fibrillation, pulmonary hypertension, heart failure with preserved ejection fraction, or prior left sided valve surgery may benefit from targeted evaluation however there is no evidence to support routine screening for tricuspid regurgitation. Some genetic conditions which might lead to tricuspid valve regurgitation may require screening and include:[2][3]
- Trisomy 21
- Trisomy 18
- Trisomy 13
- Turner syndrome
- Screening can be done by using the following in these patients, assessment of tricuspid blood flow along with the following:
- Fetal nuchal translucency (NT) thickness
- Fetal heart rate (FHR)
- Serum free beta-human chorionic gonadotropin (beta-hCG)
- Pregnancy-associated plasma protein A (PAPP-A)
References
- ↑ Hahn RT (May 2023). "Tricuspid Regurgitation". N Engl J Med. 388 (20): 1876–1891. doi:10.1056/NEJMra2216709. PMID 37195943 Check
|pmid=value (help). - ↑ Kagan KO, Valencia C, Livanos P, Wright D, Nicolaides KH (2009). "Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation". Ultrasound Obstet Gynecol. 33 (1): 18–22. doi:10.1002/uog.6264. PMID 19031473.
- ↑ Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH (2006). "Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks". Ultrasound Obstet Gynecol. 27 (2): 151–5. doi:10.1002/uog.2699. PMID 16388509.